Medtech investment in Minnesota falls back to earth
April 17, 2015 by Scott Wooldridge
After an off-the-charts year in investment for 2014, the Minnesota bioscience industry has seen a more typical 1st quarter, according to a report from medtech lobby LifeScience Alley.
Officials with the Minneapolis-based trade association said yesterday that the 1st quarter of 2015 saw $41 million in total investments in the North Star state. Most of that investment went to the medical device field, always a strong industry in the state. In Q1, 57% of the companies raising money were from the medical device field, and 87% of the total funding came in that area. Read more
Tal Medical raises $14m for non-invasive anti-depression device
April 21, 2015 by Brad Perriello
Tal Medical said today that it landed a $14 million Series B round it plans to use in backing clinical trials for its low-field magnetic stimulation technology as a non-invasive neurostimulation treatment for depression and bipolar disorder.
CSA’s main product is its truFreeze spry cryotherapy, which is designed to use super-cold liquid nitrogen delivered via catheter, to ablate unwanted tissue inside the body. Read more
CSA Medical raises another $4m for cryotherapy device
April 20, 2015 by Mark Hollmer
Maryland’s CSA Medical said last week that it’s close to reaching a $4 million funding goal with a new debt offering.
CSA’s main product is its truFreeze spry cryotherapy, which is designed to use super-cold liquid nitrogen delivered via catheter, to ablate unwanted tissue inside the body. Read more
Spirox lands $19m Series B round
April 23, 2015 by Mark Hollmer
Spirox said this week that it nailed down an $18.5 million Series B round to back development and commercialization of its device to treat patients with nasal obstructions.
Venrock and Aisling Capital led the round for Menlo Park, Calif.-based Spirox, with existing investors Aperture Venture Partners, Correlation Ventures and Western Technology Investment also participating. Read more
